As Canada is set to legalize marijuana use on Oct. 17, Walmart—the world’s largest employer—is seriously considering adding cannabis products alongside other medications in its aisles in the country, according to Hemp Industry Daily.

HHS proposed a new rule to require drug manufacturers to publish prices of medicines in television ads. However, the rule has no enforcement mechanism by the agency and relies on self-policing.

On Monday, CMS proposed a new rule that would require manufacturers to disclose drug prices in television ads. The rule was expected, as the Trump administration and HHS Secretary Alex Azar have ramped up rhetoric to put more pressure on rising drug prices.

Beginning with services performed on Jan. 1, 2019, UnitedHealthcare will be reviewing the site of care for certain CT and MR imaging procedures to be performed in an outpatient hospital setting. Anthem implemented a similar policy in 2017.

As the country's strong partisan divides become more apparent with an approaching midterm election, struggles related to the cost and accessibility of healthcare services are one top issue that both Republicans and Democrats currently agree on.

Private equity firm KKR has completed its acquisition of Envision Healthcare Corporation for a deal valued at $9.9 billion. The deal was previously announced in June.

The national uninsured rate in the U.S. has risen nearly 3 percent over the past two years, according to a WalletHub study comparing rates across 547 U.S. cities. Honolulu saw the lowest uninsured rate for large cities, while Dallas took the cake for the country’s highest uninsured rate.

The 2.3 percent medical device tax violates sound tax principles and negatively affects various segments of the healthcare industry, according to a new report released Thursday, Oct. 11, by the San Francisco, California-based Pacific Research Institute.